ARCHIVES

FDA Proposes Office For Patients With Life Threatening Disease

This article is from The Cancer Letter archive.

Vol. 18 No. 44 | November 13, 1992

Download PDF Visit The Full Archive

Related Articles

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

Breast Cancer Working Group Lists Research Needed

July 1, 1988

ACS, NBCC Weigh Involvement In March, Ask What Happens Next

October 31, 1997

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014